Melola Discovery

← Melola Discovery

Jurnal SINTA 1

Molecular Docking of Xanthone Derivatives as Therapeutic Agent for Covid-19

Molekul: Jurnal Ilmiah Kimia · Vol. 17 No. 1 (2022) · hlm. 1–9

DOI
10.20884/1.jm.2022.17.1.5600
ISSN
2503-0310, 1907-9761
Terbit
2022-03-13
Penerbit
Universitas Jenderal Soedirman
Bahasa
eng

Abstrak

Covid-19 has caused more than 14 million confirmed cases and more than 6 hundred deaths as of 21 July 2020 globally. However, there is no approved drug to treat the disease. Xanthone is a potential therapeutic option for the virus that have been tested using molecular docking. There were 12 of xanthone compounds and its derivatives which have been docked against two protein crystals, 2GX4.pdb and 6FV1.pdb, which obtained two potential compounds of hydroxyxanthone derivatives with sulfonate and chloro substitution. These compounds are potentially developed into one of the agents for the treatment of infection COVID-19 disease. Based on energy data and interactions with amino acid residues when compared with its own native ligands, namely NOL and E8E, respectively. Energy docking and energy docking interactions are equal to - 43.3057and - 45.5805 Kcal/mol respectively, during interactions with amino acid residues in the form of Gly 142, His 163, Cys144, Glu166, Gln164 and His 41. Based on these two data, it can be concluded that trihydroxyxanthone compounds 4 and 8 with chloro and sulfonate substitution are very potential to be developed as drug agents for Covid-19 disease therapy through protease inhibition.

Jaringan kolaborasi para penulis

40 penulis · 94 tautan kepenulisan bersama · 60 lintas organisasi · menampilkan 40 yang paling banyak terhubung

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • University of Mataram
  • Universitas Jambi
  • Muhammadiyah University of Yogyakarta
  • National University of Malaysia
  • Kırıkkale University
  • Universitas Hang Tuah Pekanbaru
  • Universitas Muhammadiyah Riau
  • Organisasi lain
  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Ahmad FudholiNational University of Malaysia3
Muhammad ZohriNational University of Malaysia3
Roslee RajikanNational University of Malaysia2
Nesrin AkçaKırıkkale University2
Bahtiar BahtiarUniversitas Islam Negeri Mataram1
I Gede Adhitya Wisnu WardhanaUniversity of Mataram1
Sarwa HitaUniversity of Mataram1
Nguyen Dang Hoa NghiemTrường Đại học Kỹ thuật - Công nghệ Cần Thơ1
Denai WahyuniUniversitas Hang Tuah Pekanbaru1
Wulan SariUniversitas Hang Tuah Pekanbaru1
Jasril JasrilRiau University1
Fuad MuchlisUniversitas Jambi1
ElwamendriUniversitas Jambi1
Siti KurniasihUniversitas Jambi1
Ahyauddin AhyauddinUniversitas Jambi1
Eko Nugroho PratamaUniversitas Jambi1
Nur Aini FitriUniversity of Mataram1
Ermia HidayantiUniversity of Mataram1
Sha-Ling HanChaoyang University of Technology1
Rendy Yoga ArdianMuhammadiyah University of Yogyakarta1
Aygen ÇakmakKırıkkale University1
Meltem SaygiliAfiliasi tidak diketahui1
Faturahman Fauzi AzwarjayaMuhammadiyah University of Yogyakarta1
Nurul Huda RazalliNational University of Malaysia1
Hendry Sakke TiraUniversity of Mataram1
Made WirawanUniversity of Mataram1
Samsul RahmanUniversity of Mataram1
Ekarong SukjitSuranaree University of Technology1
Afan Fatkhur AkhmadMuhammadiyah University of Yogyakarta1
Hardani HardaniPoliteknik Medica Farma Husada Mataram1
Yuyun IrmawatiIndonesian Institute of Sciences1
Shofia ManzaliniSunan Gunung Djati State Islamic University Bandung1
Bambang SugengNational Research and Innovation Agency1
Harayasu AsaharaThe University of Osaka1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OAI-PMH (metadata jurnal) https://jos.unsoed.ac.id/index.php/jm/oai, pertama di-harvest 9 Nov 2026, terakhir terlihat 9 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US"> Molecular Docking of Xanthone Derivatives as Therapeutic Agent for Covid-19</dc:title>
	<dc:creator>Yuanita, Emmy</dc:creator>
	<dc:creator>Sudirman, Sudirman</dc:creator>
	<dc:creator>Dharmayani, Ni Komang Tri</dc:creator>
	<dc:creator>Ulfa, Maria</dc:creator>
	<dc:creator>Hadisaputra, Saprizal</dc:creator>
	<dc:creator>Syahri, Jufrizal</dc:creator>
	<dc:description xml:lang="en-US">Covid-19 has caused more than 14 million confirmed cases and more than 6 hundred deaths as of 21 July 2020 globally. However, there is no approved drug to treat the disease. Xanthone is a potential therapeutic option for the virus that have been tested using molecular docking. There were 12 of xanthone compounds and its derivatives which have been docked against two protein crystals, 2GX4.pdb and 6FV1.pdb, which obtained two potential compounds of hydroxyxanthone derivatives with sulfonate and chloro substitution. These compounds are potentially developed into one of the agents for the treatment of infection COVID-19 disease. Based on energy data and interactions with amino acid residues when compared with its own native ligands, namely NOL and E8E, respectively. Energy docking and energy docking interactions are equal to - 43.3057and - 45.5805 Kcal/mol respectively, during interactions with amino acid residues in the form of Gly 142, His 163, Cys144, Glu166, Gln164 and His 41. Based on these two data, it can be concluded that trihydroxyxanthone compounds 4 and 8 with chloro and sulfonate substitution are very potential to be developed as drug agents for Covid-19 disease therapy through protease inhibition.</dc:description>
	<dc:publisher xml:lang="en-US">Universitas Jenderal Soedirman</dc:publisher>
	<dc:date>2022-03-13</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jos.unsoed.ac.id/index.php/jm/article/view/5600</dc:identifier>
	<dc:identifier>10.20884/1.jm.2022.17.1.5600</dc:identifier>
	<dc:source xml:lang="en-US">Molekul; Vol 17 No 1 (2022); 1-9</dc:source>
	<dc:source>2503-0310</dc:source>
	<dc:source>1907-9761</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://jos.unsoed.ac.id/index.php/jm/article/view/5600/2813</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2022 Molekul</dc:rights>
	<dc:rights xml:lang="en-US">http://jos.unsoed.ac.id/index.php/jm/index</dc:rights>
</oai_dc:dc>